According to Dyne Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.66. In 2022 the company made an earnings per share (EPS) of -$3.24 a decrease over its 2021 EPS that were of -$2.91.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -$3.66 | |
2022 | -$3.24 | 11.34% |
2021 | -$2.91 | 63.46% |
2020 | -$1.78 |